Valeriya Lyssenko is Professor of Medicine at University of Bergen. Her research field is pathophysiology of diabetes and associated complications with focus on underlying genetic susceptibility. Research combines large population-based studies with functional in vivo and in vitro investigations. Together with the Broad Institute (MIT/Harvard), Novartis and Lund University, she worked on a first Diabetes Genetic Initiative - a SNP atlas for type 2 diabetes published in Science 2006. She was a visiting scientific researcher at the Broad Institute/MIT in Boston (2007-2008). Dr. Lyssenko is a principal investigator and scientific leader of PROLONG and DOLCE clinical studies. She received a number of prestigious awards, SSSD Young Investigator Award (2008), Rising Star at the EASD (2009), Bagger-Sorensen Young Talent Award (2013), UiB and Bergen research foundation award (2015). She is serving on a number of international scientific review boards. Dr. Lyssenko is the author of more than 100 peer-reviewed scientific publications.